European Global Times
SEE OTHER BRANDS

The most trusted news from Europe

European Global Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.

Press releases published on April 14, 2025

VivoPower provides clarification re US$180 million enterprise value takeover proposal

VivoPower provides clarification re US$180 million enterprise value takeover proposal

Proportional takeover offer is a buyout for 8 out of 10 shares held by shareholders at a record date  Amount to be offered per share to be computed as US$180m less net debt divided by number of eligible ordinary shares at the time LONDON, April 14, 2025 ( …

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares 14 April, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 14 April 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading …

THEON publishes its FY 2024 Annual Report - Strong financial performance and significant milestones achieved Further strong growth anticipated in FY 2025

THEON publishes its FY 2024 Annual Report - Strong financial performance and significant milestones achieved Further strong growth anticipated in FY 2025

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 14 April 2025 – Theon International Plc (THEON) today publishes its FY 2024 Annual Report for the 12 months ended 31 December 2024, with the results demonstrating a very strong performance and …

AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE Paris, April 14, 2025, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the United …

AB Science reçoit un avis d’acceptation pour le brevet américain courant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet américain courant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR LE BREVET AMERICAIN COUVRANT JUSQU'EN 2040 LE MASITINIB DANS LE TRAITEMENT DE LA DREPANOCYTOSE Paris, 14 avril 2025, 18h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui que …

Yachting: M3 announces ‘World Yachting Summit’ in Monaco from April 15, experts to discuss the future of the Industry

Yachting: M3 announces ‘World Yachting Summit’ in Monaco from April 15, experts to discuss the future of the Industry

MONACO, April 14, 2025 (GLOBE NEWSWIRE) -- From April 15 to 17, Monaco will host the World Yachting Summit (WYS), an international event that will bring together the leading players in the global yachting industry. The announcement comes from M3, a leader …

Valneva Receives First Marketing Authorization for IXCHIQ®  in a Chikungunya Endemic Country

Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country

Saint Herblain (France), April 14, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose vaccine IXCHIQ …

 Valneva reçoit la première autorisation de mise sur le marché pour IXCHIQ® dans un pays où le chikungunya est endémique

Valneva reçoit la première autorisation de mise sur le marché pour IXCHIQ® dans un pays où le chikungunya est endémique

Saint Herblain (France), le 14 avril 2025 - Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l'agence de santé brésilienne (ANVISA) a accordé l'autorisation de mise sur le marché à son …

trivago N.V.'s First Quarter 2025 Earnings Release Scheduled for April 29, 2025;  Webcast Scheduled for April 30, 2025

trivago N.V.'s First Quarter 2025 Earnings Release Scheduled for April 29, 2025; Webcast Scheduled for April 30, 2025

  trivago N.V.'s First Quarter 2025 Earnings Release Scheduled for April 29, 2025; Webcast Scheduled for April 30, 2025   DÜSSELDORF, GERMANY – April 14, 2025 - trivago N.V. (NASDAQ: TRVG) announced today that it will release its financial results for the …

[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US

[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules – corrected: reference to date of product launch in Europe removed; link to “Important Safety Information” updated Company aims to accelerate access to much-needed biosimilar to …

New Mindfulness App ‘Begin’ Launches, Bringing Calm to Pets and Their Owners

New Mindfulness App ‘Begin’ Launches, Bringing Calm to Pets and Their Owners

Magikbee, expands digital wellness to four-legged family members with Begin — a mindfulness app with guided exercises and calm sounds for the whole household. BRAGA, PORTUGAL, April 13, 2025 /⁨EINPresswire.com⁩/ -- A first-of-its-kind mindfulness app is …

Holding(s) in Company

Holding(s) in Company

Reykjavík, April 14, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") Total Voting Rights and Notifications of Major Holdings TORONTO, ONTARIO – 14 April 2025 – Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ), an independent mining company with …

Houston Patent Agent Offers Nonprovisional Patent Filing Services for Startups

Houston Patent Agent Offers Nonprovisional Patent Filing Services for Startups

Affordable Patent Agency expands to Houston, offering flat-fee nonprovisional patent filing services with expert support from a registered patent agent. HOUSTON, TX, UNITED STATES, April 14, 2025 /⁨EINPresswire.com⁩/ -- Affordable Patent Agency is excited …

Equinor ASA: proposal on capital reduction from the company’s board of directors

Equinor ASA: proposal on capital reduction from the company’s board of directors

The board of directors of Equinor ASA (OSE: EQNR, NYSE: EQNR) has today decided to propose to the general meeting of the company that the company’s share capital is reduced through cancellation of own shares and redemption of shares belonging to the …

Equinor ASA: forslag om kapitalnedsettelse fra selskapets styre

Equinor ASA: forslag om kapitalnedsettelse fra selskapets styre

Styret i Equinor ASA (OSE: EQNR, NYSE: EQNR) har i dag besluttet å foreslå for selskapets generalforsamling at selskapets aksjekapital nedsettes ved sletting av egne aksjer og innløsning av aksjer tilhørende den norske stat. Forslaget fremsettes som følge …

FEXSE launches next-gen tokenization platform for real-world assets

FEXSE launches next-gen tokenization platform for real-world assets

LONDON, UK, April 14, 2025 (GLOBE NEWSWIRE) -- FEXSE launches next-gen tokenization platform for real-world assets FEXSE, a next-generation real-world asset (RWA) platform, has launched FEXSE Token Studio, a tokenization-based platform designed to …

Unimot establishes a board of strategic advisors

Unimot establishes a board of strategic advisors

WARSAW, Poland, April 14, 2025 (GLOBE NEWSWIRE) -- On April 14, Unimot, a multienergy capital group and a leader among independent importers of liquid and gaseous fuels in Poland with a strong international presence, officially inaugurated the …

VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma

VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma

— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to autologous hematopoietic cell transplantation (AHCT) — First patient dosed at City of Hope National …

Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer

Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer

Tarapchak brings more than 30 years of accounting and finance expertise to the role CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today …

Clene to Present at the Emerging Growth Conference

Clene to Present at the Emerging Growth Conference

SALT LAKE CITY, April 14, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to advancing therapies for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service